In parkinsonian substantia nigra, α-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity
Authors:
- 10 August 2007
- journal article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 114 (12) , 1559-1567
Abstract
α-Synuclein (αSYN) plays a central role in the neural degeneration of Parkinson’s disease (PD) through its conformational change. In PD, αSYN, released from the membrane, accumulates in the cytoplasm and forms Lewy body. However, the mechanism behind the translocation and conformational change of αSYN leading to the cell death has not been well elucidated. This paper reports that in the dopamine neurons of the substantia nigra containing neuromelanin from PD patients, αSYN was modified with acrolein (ACR), an aldehyde product of lipid peroxidation. Histopathological observation confirmed the co-localization of protein immunoreactive to anti-αSYN and ACR antibody. By Western blot analyses of samples precipitated with either anti-αSYN or anti-ACR antibody, increase in ACR-modified αSYN was confirmed in PD brain. Modification of recombinant αSYN by ACR enhanced its oligomerization, and at higher ACR concentrations αSYN was fragmented and polymerized forming a smear pattern in SDS-PAGE. ACR reduced 20S proteasome activity through the direct modification of the proteasome proteins and the production of polymerized ACR-modified proteins, which inhibited proteasome activity in vitro. These results suggest that ACR may initiate vicious cycle of modification and aggregation of proteins, including αSYN, and impaired proteolysis system, to cause neuronal death in PD.Keywords
This publication has 40 references indexed in Scilit:
- α‐Synuclein–synaptosomal membrane interactionsEuropean Journal of Biochemistry, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Characterization of Cytoplasmic α-Synuclein AggregatesJournal of Biological Chemistry, 2002
- Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's DiseaseBiochemistry, 2001
- Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. WrightJournal of Molecular Biology, 2001
- α-Synuclein Membrane Interactions and Lipid SpecificityJournal of Biological Chemistry, 2000
- Protein‐Bound AcroleinJournal of Neurochemistry, 1999
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997